Autolus Therapeutics (AUTL) Capital Expenditures (2019 - 2025)
Autolus Therapeutics' Capital Expenditures was -$885,000 in Q4 2025, compared with $11.11 million a year earlier.
Powered by 
Analysis
Autolus Therapeutics (AUTL) Capital Expenditures (2019 - 2025) Analysis & Trends
For FY2025, Capital Expenditures at Autolus Therapeutics came in at $19.04 million, down 13.7% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of 5.3% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $22.08 million in FY2024 (+100.9%), $10.99 million in FY2023 (+1.3%), $10.84 million in FY2022 (+22.4%) and $8.86 million in FY2021 (-39.7%).
- The Q4 2025 figure marks the lowest quarterly Capital Expenditures in data going back to Q3 2018.
- Compared with a year earlier, Capital Expenditures was higher in three of the last six quarters, with growth averaging 289.6%.
- The best year-over-year quarter for Capital Expenditures over five years was Q2 2025 (growth of 765.3%); the worst was Q1 2024 (a decline of 85.3%).
- Per Business Quant data, AUTL's Capital Expenditures in the three quarters before Q4 2025 was $4.41 million (Q3 2025), $7.28 million (Q2 2025) and $8.24 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Autolus Therapeutics | 688.78 Mn | -635.30 Mn | 25.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -885,000.00 |
| Sep 30, 2025 | 4.41 Mn |
| Jun 30, 2025 | 7.28 Mn |
| Mar 31, 2025 | 8.24 Mn |
| Dec 31, 2024 | 11.11 Mn |
| Sep 30, 2024 | 9.59 Mn |
| Jun 30, 2024 | 841,000.00 |
| Mar 31, 2024 | 533,000.00 |
| Dec 31, 2023 | 1.48 Mn |
| Sep 30, 2023 | 1.50 Mn |
| Jun 30, 2023 | 4.39 Mn |
| Mar 31, 2023 | 3.62 Mn |
| Dec 31, 2022 | 633,000.00 |
| Sep 30, 2022 | 6.80 Mn |
| Jun 30, 2022 | 2.64 Mn |
| Mar 31, 2022 | 771,000.00 |
| Dec 31, 2021 | 1.59 Mn |
| Sep 30, 2021 | 3.86 Mn |
| Jun 30, 2021 | 1.51 Mn |
| Mar 31, 2021 | 1.90 Mn |
API Access
Autolus Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();